Background illustration for clinical trials search

Paid Clinical Trials Princeton

Discover 1,670 paid clinical trials in Princeton, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies

for
Advanced Solid Malignancies
Location: New Brunswick NJ, Richmond VA, Louisville KY,
Sponsor: Georgiamune Inc

Sex: All

Age: 18+

Code: NCT06028074

Phase 1, Phase 2, Recruiting

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: New Brunswick NJ, Philadelphia PA, New York NY,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06297226

Phase 2, Recruiting

Addressing Genomic Disparities in Cancer Survivors

for
Hereditary Cancer, Genetic Testing
Location: New Brunswick NJ, Washington D.C. DC
Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 18 - 70+

Code: NCT06073626

Recruiting

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

for
Chronic Graft-versus-host-disease
Location: New Brunswick NJ, Philadelphia PA, Hackensack NJ,
Sponsor: Incyte Corporation

Sex: All

Age: 12+

Code: NCT06585774

Phase 3, Recruiting

Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma

for
Carcinoma, Hepatocellular, Liver Cell Carcinoma
Location: New Brunswick NJ, The Bronx NY
Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 18+

Code: NCT05366829

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients

for
Melanoma Stage IIIB, Melanoma Stage IIIC, Melanoma Stage IIID
Location: New Brunswick NJ, Philadelphia PA, Ney York NY,
Sponsor: Philogen S.p.A.

Sex: All

Age: 18+

Code: NCT03567889

Phase 3, Recruiting

A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer

for
Metastatic HER2-positive Breast Cancer
Location: New Brunswick NJ, Philadelphia PA, New York NY,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06435429

Phase 3, Recruiting

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

for
Superficial Bladder Cancer,
Location: New Brunswick NJ, Philadelphia PA, Voorhees Township NJ,
Sponsor: enGene, Inc.

Sex: All

Age: 18+

Code: NCT04752722

Phase 1, Phase 2, Recruiting

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

for
Non-Muscle Invasive Bladder Cancer
Location: New Brunswick NJ, Bala-Cynwyd PA, Los Alamitos CA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06319820

Phase 3, Recruiting

A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas

for
B-cell Non-Hodgkins Lymphoma (B-NHL)
Location: New Brunswick NJ, New York NY, Boston MA, Louisville KY,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05685173

Phase 1, Recruiting

Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)

for
Breast Neoplasms, Breast Cancer
Location: New Brunswick NJ, Fairfax VA, Boston MA, Kingston,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06686394

Phase 1, Phase 2, Recruiting

Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse

for
Recurrent Ganglioneuroblastoma, Recurrent Neuroblastoma,
Location: New Brunswick NJ, New York NY, Albany NY, Columbia SC,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 30

Code: NCT07437963

Phase 1, Phase 2, Recruiting

Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy

for
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma,
Location: New Brunswick NJ, Toms River NJ, Long Branch NJ,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT07504588

Phase 2, Recruiting

A Pilot Study of ctDNA-Guided Immune Checkpoint Inhibitor Duration in Patients With Advanced Melanoma.

for
Melanoma (Skin Cancer)
Location: New Brunswick NJ
Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 18 - 70+

Code: NCT07830225

Recruiting

Luminal Bladder Cancer Effective Response to Neoadjuvant Chemotherapy (LUMBER-NAC)

for
Bladder Cancer
Location: New Brunswick NJ
Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 18 - 70+

Code: NCT07762586

Phase 2, Recruiting

A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation

for
Non-small Cell Lung Cancer (NSCLC)
Location: New Brunswick NJ, Edison NJ, Arlington VA,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07566052

Phase 3, Recruiting

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

for
Anatomic Stage II Breast Cancer AJCC v8,
Location: New Brunswick NJ, Somerville NJ, Philadelphia PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07391774

Phase 3, Recruiting

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

for
Diffuse Large B-cell Lymphoma (DLBCL)
Location: New Brunswick NJ, Stony Brook NY, Baltimore MD,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06091865

Phase 3, Recruiting

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

for
Lymphoma
Location: New Brunswick NJ, Philadelphia PA, New York NY,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT07015242

Phase 2, Recruiting

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

for
Recurrent Glioblastoma, IDH-Wildtype,
Location: New Brunswick NJ, Livingston NJ, Newark NJ, New York NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05432804

Phase 1, Phase 2, Recruiting